Peripheral Blood as a Preferable Source of Stem Cells for Salvage Transplantation in Patients with Graft Failure after Cord Blood Transplantation: A Retrospective Analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 9, 2012, Pages 1407-1414

  Fuji, Shigeo ^a,b   Nakamura, Fumiaki ^b,c   Hatanaka, Kazuo ^b,d   Taniguchi, Shuichi ^e   Sato, Maho ^f   Mori, Shin Ichiro ^g   Sakamaki, Hisashi ^h   Yabe, Hiromasa ⁱ   Miyamoto, Toshihiro ^j   Kanamori, Heiwa ^k   Ueda, Yasunori ^l   Kawa, Keisei ^f   Kato, Koji ^m   Suzuki, Ritsuro ⁿ   Atsuta, Yoshiko ⁿ   Tamaki, Toshiharu ^o   Kanda, Yoshinobu ^p  

^a OSAKA POLICE HOSPITAL   (Japan)

^b Hanwa Hematological Conference   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^e TORANOMON HOSPITAL   (Japan)

^f RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^g NATIONAL CANCER CENTER HOSPITAL   (Japan)

^h TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

ⁱ TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j KYUSHU UNIVERSITY   (Japan)

^k KANAGAWA CANCER CENTER   (Japan)

^l KURASHIKI CENTRAL HOSPITAL   (Japan)

^m JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

ⁿ NAGOYA UNIVERSITY   (Japan)

^o Rinku General Medical Center   (Japan)

^p JICHI MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Engraftment; Peripheral blood stem cells; Second transplant

Indexed keywords

BUSULFAN; CALCINEURIN INHIBITOR; CLADRIBINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; FLUDARABINE; IDARUBICIN; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; ENGRAFTMENT; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; INFECTION; INTERMETHOD COMPARISON; JAPAN; LEUKOCYTE DISORDER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; MORTALITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NEWBORN; NONMYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PROGRESSION FREE SURVIVAL; REDUCED INTENSITY CONDITIONING; REGISTER; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCHOOL CHILD; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; JAPAN; LEUKEMIA; LYMPHOMA; MALE; MULTIVARIATE ANALYSIS; NEUTROPHILS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING;

EID: 84865194667     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.02.014     Document Type: Article

References (17)

1. Mattsson J., Ringdén O., Storb R. Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008, 14:165-170.
2. Eapen M., Logan B.R., Confer D.L., et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 2007, 13:1461-1468.
3. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005, 23:5074-5087. Stem Cell Trialists' Collaborative Group.
4. Rocha V., Labopin M., Sanz G., et al. Acute Leukemia Working Party of the European Blood and Marrow Transplant Group and Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004, 351:2276-2285.
5. Atsuta Y., Suzuki R., Nagamura-Inoue T., et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 2009, 113:1631-1638.
6. Rondón G., Saliba R.M., Khouri I., et al. Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation: results of a single-institution analysis. Biol Blood Marrow Transplant 2008, 14:859-866.
7. Guardiola P., Kuentz M., Garban F., et al. French Society of Bone Marrow Transplantation. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. Br J Haematol 2000, 111:292-302.
8. Waki F., Masuoka K., Fukuda T., et al. Feasibility of reduced-intensity cord blood transplantation as a salvage therapy for graft failure: results of nationwide survey of 80 adult patients. Biol Blood Marrow Transplant 2011, 17:841-851.
9. Schriber J., Agovi M.A., Ho V., et al. Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant 2010, 16:1099-1106.
10. Atsuta Y., Suzuki R., Yoshimi A., et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol 2007, 86:269-274.
11. Petersdorf E.W., Hansen J.A., Martin P.J., et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001, 345:1794-1800.
12. Bacigalupo A., Ballen K., Rizzo D., et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009, 15:1628-1633.
13. Giralt S., Ballen K., Rizzo D., et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 2009, 15:367-369.
14. Hill B.T., Bolwell B.J., Rybicki L., et al. Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants. Biol Blood Marrow Transplant 2010, 16:1738-1746.
15. Oh H., Loberiza F.R., Zhang M.J., et al. Comparison of graft-versus-host disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 2005, 105:1408-1416.
16. Hahn T., McCarthy P.L., Zhang M.J., et al. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol 2008, 26:5728-5734.
17. Ogawa H., Ikegame K., Yoshihara S., et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 2006, 12:1073-1084.